Abstract: A process is provided for encapsulating glutathione (GSH), 3,3?-diindolylmethane (DIM), coenzyme-Q10 (CoQ10), and other hydrophobic antioxidant compounds by using whey proteins which may be polymerized in a particular manner. Further, compositions comprising polymerized whey protein (PWP) encapsulated glutathione, polymerized whey protein (PWP) encapsulated CoQ10, and polymerized whey protein (PWP) encapsulated DIM are provided.
Type:
Application
Filed:
September 26, 2023
Publication date:
January 18, 2024
Applicant:
FoodScience Corporation
Inventors:
Adam Killpartrick, Mingruo Guo, Alyssa Humphrey Kemp
Abstract: A process is provided for encapsulating glutathione (GSH), 3,3?-diindolylmethane (DIM), coenzyme-Q10 (CoQ10), and other hydrophobic antioxidant compounds by using whey proteins which may be polymerized in a particular manner. Further, compositions comprising polymerized whey protein (PWP) encapsulated glutathione, polymerized whey protein (PWP) encapsulated CoQ10, and polymerized whey protein (PWP) encapsulated DIM are provided.
Type:
Grant
Filed:
August 17, 2021
Date of Patent:
September 26, 2023
Assignee:
FoodScience Corporation
Inventors:
Adam Killpartrick, Mingruo Guo, Alyssa Humphrey Kemp
Abstract: A process is provided for encapsulating glutathione (GSH), 3,3?-diindolylmethane (DIM), coenzyme-Q10 (CoQ10), and other hydrophobic antioxidant compounds by using whey proteins which may be polymerized in a particular manner. Further, compositions comprising polymerized whey protein (PWP) encapsulated glutathione, polymerized whey protein (PWP) encapsulated CoQ10, and polymerized whey protein (PWP) encapsulated DIM are provided.
Type:
Application
Filed:
August 17, 2021
Publication date:
February 24, 2022
Applicant:
FoodScience Corporation
Inventors:
Adam Killpartrick, Mingruo Guo, Alyssa Humphrey Kemp
Abstract: Compositions and methods for treating inflammatory disease and for modulating the immune system are described. The compositions and methods pertain to the use of a combination of N,N-dimethylglycine and a component derived from the mussel Perna canaliculus to achieve synergistic anti-inflammatory and immunomodulating effects.
Abstract: The invention relates to a method of treating, inhibiting the metastasis of, or preventing cervical, breast or prostate cancer comprising administering to a patient an effective amount of N,N-dimethylglycine or a pharmaceutically acceptable salt thereof.
Abstract: Compositions and methods for treating inflammatory disease and for modulating the immune system are described. The compositions and methods pertain to the use of a combination of N,N-dimethylglycine and a component derived from the mussel Perna canaliculus to achieve synergistic anti-inflammatory and immunomodulating effects.
Abstract: This invention relates to a method for treating arthritis and other systemic inflammatory conditions by treating the patient systemically with N,N-dimethylglycine.
Abstract: This invention relates to a method for inhibiting the metastasis or formation of a melanoma tumor by treating the patient with an effective amount of N,N-Dimethylglycine.
Type:
Grant
Filed:
January 9, 1989
Date of Patent:
February 19, 1991
Assignee:
Foodscience Corporation
Inventors:
Roger V. Kendall, John W. Lawson, Elizabeth A. Reap
Abstract: A process for synthetically producing N,N-Dimethyl Glycine, commonly referred to as DMG, through the neutralization of N,N-dimethyl glycine sodium salt with sulfuric acid wherein the N,N-dimethyl glycine sodium salt is prepared by reacting formaldehyde, sodium bisulfite, dimethyl amine, and sodium cyanide followed by agitation with caustic soda beads. Through the preparation and intermediate steam distillation and isolation of N,N-Dimethylamino acetonitrile. The nitrile solution is subjected to caustic hydrolysis then is subsequently neutralized leaving DMG in methanol extraction solvent. The methanol is removed in an azeotropic distillation step to produce DMG in a high yield, low cost and excellent quality.